Linn Cindy L, Webster Sarah E, Webster Mark K
Department of Biological Sciences, Western Michigan University, Kalamazoo, MI, USA.
Bio Protoc. 2018 Nov 5;8(21). doi: 10.21769/BioProtoc.3076.
Eye drop treatments are typically used to apply drugs to the anterior structures of the eye. Recently, however, studies have demonstrated that eye drops can reach the retina in the back of the eye if pharmacological agents are carried in appropriate vehicles. Here, we introduce an eye drop procedure to deliver a drug (PNU-282987), in combination with BrdU, to stimulate cell cycle re-entry and label dividing cells in the retinas of adult rodents. This procedure avoids potential systemic complications of repeated intraperitoneal injections, as well as the retinal damage that is induced by repeated intravitreal injections. Although the delivery of PNU-282987 and BrdU is the focus of this article, many different proliferating compounds could be delivered to the retina using this procedure.
眼药水治疗通常用于将药物应用于眼睛的前部结构。然而,最近的研究表明,如果药理剂通过适当的载体携带,眼药水可以到达眼睛后部的视网膜。在这里,我们介绍一种眼药水给药程序,将一种药物(PNU-282987)与BrdU联合使用,以刺激成年啮齿动物视网膜中的细胞周期重新进入并标记分裂细胞。该程序避免了重复腹腔注射可能引起的全身并发症,以及重复玻璃体内注射所诱导的视网膜损伤。尽管本文重点介绍了PNU-282987和BrdU的给药,但使用该程序可以将许多不同的增殖化合物递送至视网膜。